Brain and Behaviour: Sensitization and drugs supplementary materials

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/56

encourage image

There's no tags or description

Looks like no tags are added yet.

57 Terms

1
New cards

Nerve cells

Tiny cells that make up networks in the brain, sending signals across gaps to one another using chemical messengers.

2
New cards

Feel-good network

A brain network activated by actions essential to survival and dedicated to making us feel good.

e.g. Eating, drinking, having sex, etc

3
New cards

Dopamine

A feel-good chemical messenger released by nerve cells that travels across gaps to receptors on neighboring cells, triggering a chain reaction that produces pleasure.

4
New cards

Dopamine transporter

A mechanism that mops up dopamine sitting in the space between two nerve cells so it can return to the cell that released it.

5
New cards

Reuptake

The return of released dopamine back into the nerve cell that released it for further use

6
New cards

Reuptake (con’t)

When blocked, dopamine accumulates in the space between cells.

7
New cards

Cocaine

A substance that hijacks the feel-good network by blocking the dopamine transporter, preventing dopamine return and flooding the brain with feel-good chemicals.

8
New cards

Euphoria

A state and sense of self-assurance produced when a flood of dopamine sends the brain's feel-good network into overdrive, making the user animated and talkative.

9
New cards

Psilocybin

The main psychoactive ingredient found in magic mushrooms, which the body breaks down into psilocin upon ingestion.

10
New cards

Psilocin

The active drug metabolized from psilocybin that travels to the brain, prevents the reuptake of serotonin, and binds directly to brain receptors due to its similar chemical structure.

11
New cards

Serotonin

A neurotransmitter in the brain whose activity is increased when psilocin blocks its reuptake.

12
New cards

Hallucination

The experience of perceiving and experiencing things without any real stimulus, presenting as visual or auditory sensations, or mystical and insightful feelings.

13
New cards

Duration of psilocybin effects

A timeframe generally lasting between 33 and 8 hours8\text{ hours}, which can feel significantly longer because the drug alters the user's perception of time.

14
New cards

Temporary brain rearrangement

A phenomenon where the brain temporarily inhibits normal brain activity and immediately creates new biologically stable connections, making it difficult to distinguish reality from fantasy.

15
New cards

Hippocampus and anterior cingulate cortex

Specific regions of the brain associated with dreaming that show chemical activation following psilocybin consumption.

16
New cards

US Psilocybin Study (36 college-educated participants)

A famous laboratory study where 13\frac{1}{3} of participants rated the trip as the single most spiritually significant moment of their lives, and 79%79\% reported increased well-being and satisfaction two months later.

17
New cards

UK Comparative Drug Study

A study determining that magic mushrooms cause the least amount of damage to both the individual user and to others when compared to other recreational drugs.

18
New cards

Toxicity and addiction profile of shrooms

The clinical determination that magic mushrooms are not considered clinically addictive and produce very little toxicity to other organ systems.

19
New cards

Aplysia californica

The marine mollusk used by Eric Kandel and his colleagues at Columbia University to study elemental forms of behavioral and synaptic plasticity.

20
New cards

Habituation

The process that causes an animal to become less responsive to repeated occurrences of a stimulus,

e.g. The weakening of the gill withdrawal reflex following repeated siphon stimulation in Aphlysia

21
New cards

Sensitization

A form of behavioral plasticity that allows an animal to generalize an aversive response elicited by a noxious stimulus to a variety of other non-noxious stimuli.

22
New cards

Abdominal ganglion

The structure in the Aplysia nervous system where the cell bodies of many neurons involved in gill withdrawal can be recognized by their size, shape, and position.

23
New cards

Synaptic depression

A presynaptic decrease in transmission at the glutamatergic synapse between sensory and motor neurons during habituation, caused by a reduction in the number of synaptic vesicles available for release.

24
New cards

Modulatory interneurons

Facilitating interneurons excited by sensory neurons innervating the tail that release serotonin onto the presynaptic terminals of siphon sensory neurons.

25
New cards

Serotonin (con’t)

A neurotransmitter released by modulatory interneurons that binds to G-protein coupled receptors on siphon sensory neuron terminals to enhance transmitter release.

26
New cards

Adenylyl cyclase

An enzyme activated by dissociated G-protein subunits that stimulates the production of the second messenger cyclic AMP from ATP.

27
New cards

Protein kinase A (PKA)

A kinase whose regulatory subunits bind cyclic AMP, freeing catalytic subunits to phosphorylate potassium channels during short-term sensitization and CREB during long-term sensitization.

28
New cards

Potassium channels

Ion channels on siphon sensory neurons phosphorylated by PKA

29
New cards

Potassium channels (con’t)

Their closure prolongs depolarization and increases the influx of calcium ions into the presynaptic terminal.

30
New cards

Short-term sensitization

An enhancement of the gill withdrawal reflex lasting approximately one hour following a single tail shock

31
New cards

Short-term sensitization (con’t)

It’s mediated by a signal transduction cascade that increases calcium influx without new protein synthesis.

32
New cards

CREB

A cyclic AMP response element-binding protein (transcriptional activator phosphorylated by PKA) that binds to cyclic AMP response elements (CREs) in nuclear DNA to increase downstream gene transcription.

33
New cards

CREs (Crees)

Cyclic AMP response elements located in regulatory regions of nuclear DNA that are bound by activated CREB to increase gene transcription rates.

34
New cards

Ubiquitin hydroxylase

An enzyme synthesized following CREB activation that stimulates the degradation of the regulatory subunit of PKA

35
New cards

Ubiquitin hydroxylase (con’t)

It results in persistent catalytic PKA activity that no longer requires serotonin.

36
New cards

CEP B

A transcription factor activated by CREB that stimulates transcription of genes responsible for the addition of synaptic terminals between sensory and motor neurons.

37
New cards

Long-term sensitization

A prolonged enhancement of the gill withdrawal response lasting for days or weeks after repeated tail shocks

38
New cards

Long-term sensitization (con’t)

It’s mediated by changes in gene expression, protein synthesis, and the growth of new synaptic connections.

39
New cards

Neurons

The cells that process information in the brain by transmitting signals to one another.

40
New cards

Neurotransmitters

Chemicals released from the axon of one neuron to the dendrite of another that change the electrical charge of the receiving neuron, exciting or inhibiting it.

41
New cards

Cannabonoids

Specialized neurotransmitters released by neurons that have just fired

42
New cards

Cannabonoids (con’t)

They resemble molecules found in cannabis that naturally circulate at much lower quantities in the brain.

43
New cards

Tetrahydrocannabinol (THC)

The specific chemical in cannabis that resembles the brain's natural transmitter called anandamide.

44
New cards

Anandamide

A natural neurotransmitter produced in the brain that is structurally mimicked by tetrahydrocannabinol (THC).

45
New cards

Refractory period

A temporary state of unresponsiveness after a neuron fires to prevent overreacting

46
New cards

Refractory period (con’t)

It’s removed in active neurons by cannabinoids, magnifying thoughts, perception, and imagination.

47
New cards

Dopamine and norepinephrine

Neurotransmitters in the brain whose levels are altered by cannabonoids, often producing euphoria, relaxation, pain modulation, general experiential enhancement, or occasionally anxiety.

48
New cards

Cannabonoid receptors

Receptors located in brain regions responsible for controlling short-term memory, learning, coordination, movement control, and higher cognitive functions.

49
New cards

Opiate

A chemical derived from opium

50
New cards

Opiate (con’t)

It’s a key ingredient in heroin

51
New cards

Opiate like (Opioids)

Man-made prescription drugs

e.g. Codeine, oxycodone, hydrocodone

52
New cards

How do opiates and opioids affect the brain?

They exert powerful pain relief and spread across the body by attaching to millions of opiate receptors

53
New cards

How does dependence and abuse come about from opioid use?

Taking in too many opioids can overwhelm the systems

54
New cards

Health effects of opiates

They can slow down breathing and heart rate

55
New cards

Health effects of opiates (con’t)

Mixing opiates with other substances like alcohol can create even more slowdown

56
New cards

Opiate overdose death statistics

1 person dies from an accidental overdose every 19 minutes

57
New cards

Ways to avoid opiate addiction and death

  • Don’t take more than the prescribed amount

  • Don’t mix opiates with other substances like alcohol

  • Don’t use other people’s prescriptions

  • Exercising

  • Trying alternatives like over-the-counter options